A spokesperson for Novo Nordisk, which makes Ozempic and Wegovy, said: Pregnancy or intention to become pregnant were exclusion criteria in our trials with semaglutide in both obesity and type 2 diabetes
In addition, transforming growth factor-1 (TGF-1), a potent fibrogenic protein, is known to upregulate astrocyte synthesis of proteoglycans causing severe gliosis (Yin et al., 2009
GLP-1 diabetic and weight-loss medications slow the stomach emptying
Ozempic : Personal or family history of MTC or in patients with multiple endocrine neoplasia syndrome type 2 (MEN 2) and severe hypersensitivity reaction to semaglutide or any excipients in Ozempic
BPC-157 supports the remodeling phase, which begins at approximately 3 weeks post-op and continues for months
The prescribing information for Wegovy includes warnings about thyroid cancer (which has been seen in rodent studies but not in human trials), acute pancreatitis, gallbladder and kidney problems, hypoglycemia (low blood sugar) and eye problems